Brief: Newbury Pharmaceuticals Enters Into New Partnership
March 18 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: ENTERED INTO A NEW PARTNERSHIP FOR PRUCALOPRIDE TABLETS SIGNED A CONTRACT WITH A NEW PARTNER TO REGISTER AND LAUNCH PRUCALOPRIDE IN SWEDEN REGULATORY APPROVAL IS EXPECTED IN THE NEAR FUTURE, WITH A PLANNED LAUNCH IN SWEDEN LATER THIS YEAR Source text: (Full Story) Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln